Trusted Care

Trusted Care

We see you through every step of treatment and recovery.

We see you through every step of treatment and recovery.

More...
Excellence in Cardiovascular Care

Excellence in Cardiovascular Care

MHVI cardiologists and surgeons have made Mercy Hospital one of the nation's top 50 cardiovascular hospitals.

Once again MHVI cardiologists and surgeons have made Mercy Hospital one of the nation's top 50 cardiovascular hospitals.  

More...
Here for Our Communities

Here for Our Communities

From the very beginning, we dedicated ourselves to the patients and strove for excellence in our communities.

From the very beginning, we dedicated ourselves to the patients and strove for excellence in our communities.

More...
Meet Our Team

Meet Our Team

The physicians, nurses, and staff at the Metropolitan Heart and Vascular Institute deliver care with excellence, compassion, and personal attention.

The physicians, nurses, and staff at MHVI deliver care with excellence, compassion, and personal attention.

More...
Patient Stories

Patient Stories

Read what our patients say about their experience at MHVI.

Read what our patients say about their experience at MHVI.  

More...
Frontpage Slideshow | Copyright © 2006-2012 JoomlaWorks Ltd.

The physicians, nurses, and staff at the Metropolitan Heart and Vascular Institute deliver care with excellence, compassion, and personal attention. We offer a full range of cardiovascular services, from prevention of  disease, to state-of-the-art diagnostics, to the latest in cutting edge procedural and surgical therapies. We excel in life-saving therapies because our focus is always on the patient.

Dr. Jeffrey Chambers, lead investigator of the ORBIT II study presents promising data at the Cardiovascular Research Technologies 2014 conference regarding a new therapy to treat blockages in severely calcified coronary arteries.

 

 

MHVI patient Stephen Byboth became the first person in the state to receive the Medtronic Reveal Linq on March 4, 2014. This miniscule medical device, smaller than a AAA battery, was implanted in Mr. Byboth’s chest to evaluate his symptoms of palpitations and near-fainting, which to this day continue to elude diagnosis.  It will enable his cardiologists to monitor his heart rhythm continuously, for up to three years.